Bristol-Myers Squibb names new general manager of Devens facility

In this role, Mr Perley will be responsible for continuing the supervision of the project to build the Devens facility and will have overall management responsibility for the site and facility when it becomes operational in 2011.

Prior to joining Bristol-Myers Squibb, Mr Perley was vice president of network strategy at Wyeth Biotech. Mr Perley holds a master of science degree in biochemical engineering and a bachelor of science degree in chemical engineering from the Massachusetts Institute of Technology, as well as MBA degree from Boston University’s executive program.

Carlo Notaristefani, president of technical operations at Bristol-Myers Squibb, said: “As the company evolves toward a next-generation BioPharma model, combining the best of biotech with the best of a traditional pharmaceutical company, biologics will play an increasingly important role in driving our company’s future growth and success, and will be key in helping patients prevail over serious disease. Chris brings extensive biopharmaceutical experience that will support the company in this transition.”